TDs to probe adverse side-effects of medicines
The setting-up of the committee was prompted by a number of incidents, he added, including the recent case in England where a drug trial which went wrong left six previously-healthy young men seriously ill.
In return for payment of €2,900 (£2,000) apiece, the men had volunteered to participate in the first human trials of TGN1412, a drug whose German manufacturer hoped would treat rheumatoid arthritis, leukaemia and multiple sclerosis.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



